Kathryn Chapman - Concepedia

Author

Kathryn Chapman

National Centre for the Replacement Refinement and Reduction of Animals in Research

Also Known As

Chapman, Katherine E., Chapman, Kathryn, K Chapman, K. Chapman, K.R. Chapman, Kathryn Chapman, Kathryn L Chapman, Kathryn L. Chapman, Kenneth R. Chapman

100

Publications

3.9K

Citations

H-Index

138

Concepts

All Affiliations

National Centre for the Replacement Refinement and Reduction of Animals in Research GlaxoSmithKline (United Kingdom)AstraZeneca (United Kingdom)Imperial College London Charles River Laboratories (United Kingdom)

About

Kathryn Chapman is an author at National Centre for the Replacement Refinement and Reduction of Animals in Research specializing in medicine, pharmacology, and toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.7K
2	Engineering	4	4	191
3	Health Sciences	3	3	180
4	Public Health	3	3	402
5	Natural Sciences	2	2	214

Kathryn Chapman

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Does age matter? The impact of rodent age on study outcomes Samuel J. Jackson, Nick Andrews, D.I. Ball, Laboratory Animals AgingRodent EcologyBiogerontologyPsychologyLaboratory Animal Study	2016	352
Cartilage Oligomeric Matrix Protein Interacts with Type IX Collagen, and Disruptions to These Interactions Identify a Pathogenetic Mechanism in a Bone Dysplasia Family Paul Holden, Roger S. Meadows, Kathryn Chapman, Journal of Biological Chemistry	2001	220
Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia Kathryn Chapman, Geert Mortier, Kay Chapman, Nature Genetics Disease MechanismGenetic DisorderMedicineGeneticsPathology	2001	202
Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs). Natalie Burden, Kathryn Chapman, Fiona Sewell, PubMed ImmunologyScience EthicUnited KingdomResearch EthicsLaboratory Animal Study	2015	157
Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against<i>Listeria monocytogenes</i> Heather M. Knowles, Justin W. Heizer, Yuan Li, Proceedings of the National Academy of Sciences Microbial PathogensInnate Immune SystemImmune RegulationImmunologyImmunologic Mechanism	2011	143
Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation Kathryn Chapman, Henry H. Holzgrefe, Lauren E. Black, Regulatory Toxicology and Pharmacology GynecologyToxicology TestingHuman TranslationTranslational MedicinePharmaceutical Toxicology	2013	132
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo Lorna R. Fiedler, Kathryn Chapman, Min Xie, Cell stem cell	2019	106
A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development Sally Robinson, Jean‐Luc Delongeas, Elizabeth Donald, Regulatory Toxicology and Pharmacology Drug SafetyRegulatory RequirementMedicineDrug DiscoveryAdverse Drug Reaction	2007	104
Preclinical development of monoclonal antibodies Kathryn Chapman, Nick Pullen, Lee Coney, mAbs ImmunologyMab DevelopmentImmunotherapyLaboratory Animal StudyTranslational Medicine	2009	95
Automated recording of home cage activity and temperature of individual rats housed in social groups: The Rodent Big Brother project William S. Redfern, Karen Tse, Claire Grant, PLoS ONE EngineeringBiometricsWearable TechnologyCommunicationIndividual Rats	2017	86

Page 1